Translational Medicine Researcher

Now Hiring

Positions

Translational Medicine Researcher

Biotherapeutics Inc
http://www.biotherapeuticsinc.com/
Location: 1800 Kraft Dr., Suite 200, Blacksburg, VA, 24060, US
Job Type: Full or Part time
Education: B.S. or greater
Job Level: Minimum 1 year relevant experience

The Position:
Biotherapeutics Inc is looking for a highly motivated Translational Medicine Researcher with experience in cutting-edge experimental technologies to advance novel therapeutics in the drug discovery pipeline. The ideal candidate will be well-versed in mucosal immunity to support pre-clinical and clinical studies.

Responsibilities:

Work independently and collaboratively in a matrixed environment

Assume the role of project manager and generate supportive data for pre-clinical experiments

Assay optimization to characterize immunity at the molecular, cellular and tissue levels

Maintain and stock materials/reagents/products used in laboratory procedures

Create reports for experimental results and communicate them to a transdisciplinary team

Job Experience:

B.S. or M.S.

1 year minimum of relevant wet-lab experience required

Desired skills:

Knowledge of mucosal immunity

Experience implementing murine models of immune-mediated and infectious diseases

especially inflammatory bowel disease, diabetes and influenza

RNA/DNA purification and characterization

Sample processing for sequencing applications

Multi-parameter flow cytometry staining and analysis

ELISA-based assay optimization

Western blot assay optimization

Analytical software: PRISM, FACS Diva, FlowJo, Excel, SAS

Demonstrated experience analyzing, interpreting and presenting experimental data

Familiarity with drug development process highly desired

Organized with strong written and verbal communication skills

About Biotherapeutics:
BioTherapeutics (BTI) is a science-based company advancing pharmaceuticals, nutritionals, and informatics using disruptive precision medicine technology for conquering inflammation and diabetes. Through significant NIH funding (+$12M) in grants, the company holds numerous US and international patents on innovative mechanisms of anti-inflammatory and anti-diabetic action. The technology was validated with over 120 mouse studies with >1000 mice resulting in 9 peer reviewed publications elucidating the pathway and showing the compounds to be both safe and effective. Currently the company is expanding rapidly to support additional pre-clinical efficacy studies and product development pipelines with the goals of submitting an investigational new drug (IND) application to the Food and Drug Administration (FDA) and launching a medical food product within 12-18 months.